Year archive

Lepu Biopharma Co., Ltd. — 2023 filings

All 52 regulatory filings released by Lepu Biopharma Co., Ltd. (2157) in 2023, sourced directly from the official regulator.

52 Filings

2023 Period

2023 filings (52)

Filing	Released	Lang
VOLUNTARY ANNOUNCEMENT COMPLETION OF PATIENT ENROLLMENT OF PIVOTAL PHASE IIb CLINICAL TRIAL FOR MRG003 FOR THE TREATMENT OF R/M NPC Regulatory Filings	2023-12-28	English
ANNOUNCEMENT IN RELATION TO THE CONTINUING CONNECTED TRANSACTION THE SUPPLEMENTAL CDMO SERVICES FRAMEWORK AGREEMENT AND THE PROPOSED REVISED CAP Regulatory Filings	2023-12-22	English
CONTINUING CONNECTED TRANSACTION NEW PROCUREMENT FRAMEWORK AGREEMENT Regulatory Filings	2023-12-22	English
VOLUNTARY ANNOUNCEMENT ORPHAN-DRUG DESIGNATION GRANTED BY THE FDA TO MRG004A FOR THE TREATMENT OF PANCREATIC CANCER Regulatory Filings	2023-12-14	English
ANNOUNCEMENT DELAY IN DESPATCH OF CIRCULAR AND CANCELLATION OF BOOK CLOSURE PERIOD Regulatory Filings	2023-12-08	English
CLOSURE OF REGISTER OF MEMBERS FOR THE 2023 SECOND EXTRAORDINARY GENERAL MEETING TO BE HELD ON DECEMBER 22, 2023 Regulatory Filings	2023-12-04	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2023 Regulatory Filings	2023-12-04	English
VOLUNTARY ANNOUNCEMENT FAST TRACK DESIGNATION GRANTED BY THE FDA TO MRG003 FOR THE TREATMENT OF R/M NPC Regulatory Filings	2023-12-04	English
ANNOUNCEMENT POSTPONEMENT OF EXTRAORDINARY GENERAL MEETING AND CANCELLATION OF BOOK CLOSURE PERIOD Regulatory Filings	2023-11-17	English
NOTICE OF THE 2023 SECOND EXTRAORDINARY GENERAL MEETING Regulatory Filings	2023-11-14	English
PROXY FORM FOR USE AT THE 2023 SECOND EXTRAORDINARY GENERAL MEETING Proxy Solicitation & Information Statement	2023-11-14	English
RESOLUTIONS RELATING TO THE PROPOSED ADDITIONAL METHOD FOR THE PUBLIC TRADING ON THE PRC DOMESTIC CAPITAL MARKET AND PROPOSED AMENDMENTS TO THE ARTICLES ANCILLARY TO THE PROPOSED QUOTATION Regulatory Filings	2023-11-14	English
(1) RESOLUTIONS RELATING TO THE PROPOSED ADDITIONAL METHOD FOR THE PUBLIC TRADING ON THE PRC DOMESTIC CAPITAL MARKET; (2) PROPOSED AMENDMENTS TO THE ARTICLES ANCILLARY TO THE PROPOSED QUOTATION&# Proxy Solicitation & Information Statement	2023-11-14	English
CONTINUING CONNECTED TRANSACTION CDMO SERVICES FRAMEWORK AGREEMENT Regulatory Filings	2023-11-13	English
CLOSURE OF REGISTER OF MEMBERS FOR THE 2023 SECOND EXTRAORDINARY GENERAL MEETING TO BE HELD ON NOVEMBER 29, 2023 Regulatory Filings	2023-11-09	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2023 Regulatory Filings	2023-11-03	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2023 Regulatory Filings	2023-10-03	English
DISCLOSEABLE TRANSACTION DISPOSAL OF 15% EQUITY INTEREST IN AN ASSOCIATE Capital/Financing Update	2023-09-29	English
2023 Interim Report Interim / Quarterly Report	2023-09-22	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2023 Regulatory Filings	2023-09-05	English
POLL RESULTS OF THE 2023 FIRST EXTRAORDINARY GENERAL MEETING HELD ON AUGUST 25, 2023 Declaration of Voting Results & Voting Rights Announcements	2023-08-25	English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2023 Interim / Quarterly Report	2023-08-25	English
NOTICE OF BOARD MEETING Regulatory Filings	2023-08-15	English
PROXY FORM FOR USE AT THE 2023 FIRST EXTRAORDINARY GENERAL MEETING Proxy Solicitation & Information Statement	2023-08-09	English
NOTICE OF THE 2023 FIRST EXTRAORDINARY GENERAL MEETING Regulatory Filings	2023-08-09	English
PROPOSED EXTENSION OF THE VALIDITY PERIOD OF THE RESOLUTIONS CONCERNING THE PROPOSED ISSUE OF A SHARES AND LISTING ON THE SCI-TECH BOARD, PROPOSED EXTENSION OF THE VALIDITY PERIOD OF THE RESOLUTION AU Proxy Solicitation & Information Statement	2023-08-09	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2023 Regulatory Filings	2023-08-04	English
ARTICLES OF ASSOCIATION Governance Information	2023-08-01	English
VOLUNTARY ANNOUNCEMENT IN RELATION TO THE PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION Board/Management Information	2023-08-01	English
PROPOSED EXTENSION OF THE VALIDITY PERIOD OF THE RESOLUTIONS CONCERNING THE ISSUE OF A SHARES AND LISTING ON THE SCI-TECH BOARD AND OTHER ANCILLARY RESOLUTIONS AND CLOSURE OF REGISTER OF MEMBERS Capital/Financing Update	2023-07-11	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2023 Regulatory Filings	2023-07-03	English
POLL RESULTS OF THE 2022 ANNUAL GENERAL MEETING AND CLASS MEETINGS HELD ON JUNE 15, 2023 Declaration of Voting Results & Voting Rights Announcements	2023-06-15	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2023 Share Issue/Capital Change	2023-06-06	English
Proxy Form for the 2023 First Class Meeting of Domestic Shareholders Proxy Solicitation & Information Statement	2023-05-24	English
Proxy Form for the 2023 First Class Meeting of H Shareholders Proxy Solicitation & Information Statement	2023-05-24	English
Proxy Form for the Annual General Meeting to be held on June 15 2023 AGM Information	2023-05-24	English
(1) 2022 REPORT OF THE BOARD OF DIRECTORS (2) 2022 REPORT OF THE BOARD OF SUPERVISORS (3) 2022 ANNUAL REPORT (4) 2022 FINANCIAL ACCOUNTS REPORT (5) 2023 FINANCIAL BUDGET (6) 2022 ANNUAL PROFIT DISTRIB AGM Information	2023-05-24	English
NOTICE OF THE 2023 FIRST CLASS MEETING OF DOMESTIC SHAREHOLDERS Regulatory Filings	2023-05-24	English
NOTICE OF THE 2023 FIRST CLASS MEETING OF H SHAREHOLDERS Proxy Solicitation & Information Statement	2023-05-24	English
NOTICE OF THE 2022 ANNUAL GENERAL MEETING AGM Information	2023-05-24	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2023 Regulatory Filings	2023-05-03	English
CLOSURE OF REGISTER OF MEMBERS FOR ANNUAL GENERAL MEETING TO BE HELD ON JUNE 15, 2023 AGM Information	2023-04-26	English
Terms of Reference for Remuneration and Appraisal Committee Remuneration Information	2023-04-26	English
2022 Annual Report Annual Report	2023-04-26	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2023 Regulatory Filings	2023-04-04	English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2022 Annual Report	2023-03-17	English
NOTICE OF BOARD MEETING Regulatory Filings	2023-03-06	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2023 Regulatory Filings	2023-03-02	English
INSIDE INFORMATION ANNOUNCEMENT EXCLUSIVE LICENSE AGREEMENT WITH ASTRAZENECA FOR CMG901 Capital/Financing Update	2023-02-23	English
VOLUNTARY ANNOUNCEMENT UPDATE ON THE DATA FROM PHASE Ia CLINICAL STUDY OF CMG901 PRESENTED AT THE 2023 ASCO GI CANCERS SYMPOSIUM Regulatory Filings	2023-02-05	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2023 Regulatory Filings	2023-02-02	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2022 Regulatory Filings	2023-01-05	English